Ginger, scientifically known as Zingiber officinale, is a plant whose roots possess anti-inflammatory, analgesic, and anti-hypertensive properties. It has been demonstrated that ginger can naturally reduce inflammation and pain. Despite these benefits, many consumers find it difficult to regularly take ginger-based supplements due to its strong taste and the occasional heartburn that can accompany traditional supplements.

IPS stands out as a leading supplier in the field of microcapsules containing ginger essential oil. Using coacervation microencapsulation technology, IPS has developed a formulation that not only preserves the therapeutic properties of ginger but also addresses issues related to its pungent taste and gastrointestinal side effects.

IPS's microcapsules, obtained through aqueous phase coacervation, can be coated with a gastro-resistant membrane, useful for delivering the active substances of ginger, such as gingerols and shogaols, directly to the intestinal level, thereby increasing therapeutic efficacy. The polymeric membrane also serves another important role: to protect the gastric mucosa from potential inflammations.

IPS's ginger microcapsules have a particle size ranging from 100 to 600 μm and an oil content between 80% and 85%. These technical characteristics provide the opportunity to produce highly effective dietary supplements with enormous formulation versatility. The microcapsules can be integrated into various solid oral formulations such as hard capsules, single-dose vials with a dosing cap, and single-dose sachets, while keeping the therapeutic characteristics of the oil unchanged.

IPS's microcapsules, with their advanced technology, not only overcome challenges related to the pungent taste and side effects of ginger for consumers but also open new frontiers in the effectiveness and acceptability of these supplements.